Search results for “CD134” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 153 patents, we discovered top 36 key players by total patent application. Biocerox Products BV, Janssen Pharmaceuticals, Inc., Kyowa Kirin Co., Ltd. are dominant in this area. They take 65.36% of the total patent filing.
Biocerox Products BV
Utrecht, Netherlands
Patent: 56
Janssen Pharmaceuticals, Inc.
New Jersey, United States
Patent: 28
Kyowa Kirin Co., Ltd.
Tokyo-to, Japan
Patent: 16
WuXi Biologics Ireland Ltd.
Ireland
Patent: 12
St. Vincent's Hospital Sydney Pty Ltd.
New South Wales, Australia
Patent: 10
BeiGene Ltd.
Massachusetts, United States
Patent: 9
Genentech, Inc.
California, United States
Patent: 6
UCB Pharma SA
Spain
Patent: 5
Magenta Therapeutics, Inc.
Massachusetts, United States
Patent: 3
OncoSec Medical, Inc.
California, United States
Patent: 3
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 49 patents applied in the last 5 years. We discover 13 most active companies in this area. The fast-growing WuXi Biologics Ireland Ltd., BeiGene Ltd., Biocerox Products BV take 59.18% of patent filing during this period.
WuXi Biologics Ireland Ltd.
Ireland
Patent: 12
BeiGene Ltd.
Massachusetts, United States
Patent: 9
Biocerox Products BV
Utrecht, Netherlands
Patent: 8
Janssen Pharmaceuticals, Inc.
New Jersey, United States
Patent: 4
Magenta Therapeutics, Inc.
Massachusetts, United States
Patent: 3
Kyowa Kirin Co., Ltd.
Tokyo-to, Japan
Patent: 2
OncoSec Medical, Inc.
California, United States
Patent: 2
The Johns Hopkins University
United States
Patent: 2
REMD Biotherapeutics, Inc.
California, United States
Patent: 2
F-Star Beta Ltd.
Cambridgeshire, United Kingdom
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 49 patents in last 5 years, we discover 8 new entrants. WuXi Biologics Ireland Ltd., BeiGene Ltd., Magenta Therapeutics, Inc. are the most active new entrants in this area.
WuXi Biologics Ireland Ltd.
Ireland
Patent: 12
BeiGene Ltd.
Massachusetts, United States
Patent: 9
Magenta Therapeutics, Inc.
Massachusetts, United States
Patent: 3
REMD Biotherapeutics, Inc.
California, United States
Patent: 2
Beijng Immunoah Pharma Tech Co., Ltd.
China
Patent: 1
F-Star Beta Ltd.
Cambridgeshire, United Kingdom
Patent: 1
Wuxi Biologics (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 1
Taize Huikang Biological Medicine Co., Ltd.
China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 10 patents, we discovered top 1 universities and scientific research institutions by total patent application.
The Johns Hopkins University
United States
Patent: 3
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: